HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ

被引：0
|
作者：
E Rakovitch
S Nofech-Mozes
W Hanna
S Narod
D Thiruchelvam
R Saskin
J Spayne
C Taylor
L Paszat
机构：
[1] University of Toronto,Department of Radiation Oncology University of Toronto
[2] Sunnybrook Health Sciences Centre,Department of Pathology
[3] University of Toronto,undefined
[4] 2075 Bayview Avenue,undefined
[5] Toronto M4N 3M5,undefined
[6] Canada,undefined
[7] Institute of Clinical Evaluative Sciences,undefined
[8] University of Toronto,undefined
[9] Women's College Hospital Research Institute,undefined
[10] University of Toronto,undefined
来源：
British Journal of Cancer | 2012年 / 106卷
关键词：
DCIS; biomarkers; recurrence; breast-conserving surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1160 / 1165
页数：5
相关论文
共 50 条
  • [21] Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in inv'asive mammary ductal carcinoma associated with ductal carcinoma in situ (DCIS) versus invasive breast cancer alone
    Mylonas, I
    Makovitzky, J
    Jeschke, U
    Briese, V
    Friese, K
    Gerber, B
    ANTICANCER RESEARCH, 2005, 25 (3A) : 1719 - 1723
  • [22] Expression of HER2neu in Ductal Carcinoma in situ is Associated with Local Recurrence
    Han, K.
    Nofech-Mozes, S.
    Narod, S.
    Hanna, W.
    Vesprini, D.
    Saskin, R.
    Taylor, C.
    Kong, I.
    Paszat, L.
    Rakovitch, E.
    CLINICAL ONCOLOGY, 2012, 24 (03) : 183 - 189
  • [23] Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer
    Cubukcu, E.
    Kanat, O.
    Olmez, O. Fatih
    Kabul, S.
    Canhoroz, M.
    Avci, N.
    Deligonul, A.
    Hartavi, M.
    Cubukcu, S.
    Olmez, F.
    Kurt, E.
    Evrensel, T.
    Gokgoz, S.
    Manavoglu, O.
    JOURNAL OF BUON, 2013, 18 (02): : 359 - 365
  • [24] Molecular Expression Assays Improve the Prediction of Local and Invasive Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ
    Hahn, Ezra
    Sutradhar, Rinku
    Paszat, Lawrence
    Nguyen, Lena
    Rodin, Danielle
    Nofech-Mozes, Sharon
    Trebinjac, Sabina
    Jerzak, Katarzyna J.
    Fong, Cindy
    Rakovitch, Eileen
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (27)
  • [25] Expression of Her2/Neu and Ki-67 proliferation index in gall bladder carcinomas: Clinicopathological significance
    Singh, N.
    Dhal, I.
    Lali, B. S.
    Chowdhury, Z.
    Patne, S.
    ANNALS OF ONCOLOGY, 2022, 33 (08) : S1419 - S1419
  • [26] The prognostic role of HER2 expression in ductal breast carcinoma in situ
    Borgquist, Signe
    Zhou, Wenjing
    Jirstrom, Karin
    Amini, Rose-Marie
    Sollie, Thomas
    Sorlie, Therese
    Butt, Saima
    Blomqvist, Carl
    Warnberg, Fredrik
    CANCER RESEARCH, 2015, 75
  • [27] ER, PR, Her2, and Ki-67 Expression in Male and Female Breast Cancer
    Lockyer, M. G.
    Martinez-Blanco, E.
    Verstovsek, G.
    Bedrosian, I.
    Albarracin, C.
    Rosen, D.
    MODERN PATHOLOGY, 2013, 26 : 54A - 55A
  • [28] ER, PR, Her2, and Ki-67 Expression in Male and Female Breast Cancer
    Lockyer, M. G.
    Martinez-Blanco, E.
    Verstovsek, G.
    Bedrosian, I.
    Albarracin, C.
    Rosen, D.
    LABORATORY INVESTIGATION, 2013, 93 : 54A - 55A
  • [29] No increased Ki67 expression in ductal carcinoma in situ associated with invasive breast cancer
    Hoque, A
    Menter, DG
    Sahin, AA
    Sneige, N
    Lippman, SM
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2001, 10 (02) : 153 - 154
  • [30] Mitochondrial DNA alterations correlate with the pathological status and the immunological ER, PR, HER-2/neu, p53 and Ki-67 expression in breast invasive ductal carcinoma
    Lin, Chen-Sung
    Chang, Shi-Chuan
    Ou, Liang-Hung
    Chen, Chien-Ming
    Hsieh, Sophie Swen-Wan
    Chung, Yu-Ping
    King, Kuang-Liang
    Lin, Shoei-Loong
    Wei, Yau-Huei
    ONCOLOGY REPORTS, 2015, 33 (06) : 2924 - 2934
12345